FOCUS

Study Sponsor: National Heart Lung & Blood Institute (NHLBI)

Principal Investigator: Timothy D. Henry, MD

Study Status: CLOSED TO ENROLLMENT

Study Synopsis: The goal of this study is to determine the effectiveness of injecting one’s own stem cells, delivered by catheter (tube) into region of the heart with poor blood flow. Stem cells are simple cells produced by the bone marrow that can develop into blood cells or other types of cells. It is possible that these cells will grow into very small blood vessels that may bring blood to your heart which may relieve angina (most commonly as chest pain) and/or congestive heart failure. The Stem Cells will be taken from your bone marrow. The Stem Cells or placebo will be delivered into your heart muscle during a cardiac catheterization and mapping procedure. Eighty-seven patients from 5 enrolling centers in the US will participate in this clinical trial.

How do I qualify?  It is possible you would qualify for the study if you are:

(a) over 18 years old

(b) have an ejection fraction <45%

(c) have reversible ischemia (area of your heart that does not get enough blood but is still viable muscle)

(d) have no other options for angioplasty, stent placement or surgery to relieve your heart disease symptoms. 

Who do I contact for more information? Rachel Olson, RN, MS, CCRC or contact research at 612.863.3980